16 December 2016
: Case report
Intrathecal Analgesic Drug Delivery is Effective for Analgesia in a Patient with Post-Poliomyelitis Syndrome: A Case Report
Unusual setting of medical care, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Cornelis W.J. van Tilburg1ABCDEF*DOI: 10.12659/AJCR.901157
Am J Case Rep 2016; 17:957-962
Abstract
BACKGROUND: Post-poliomyelitis syndrome (PPS) is a progressive neuromuscular syndrome, with chronic pain being one of the most prevalent symptoms. We present a case report on intrathecal analgesic drug delivery to diminish chronic, refractory pain in a patient with PPS.
CASE REPORT: In a wheelchair-bound 45-year-old female patient (Caucasian, body mass index [BMI] 20.5) with severe chronic, refractory pain, a Synchromed® II pump (Medtronic, Minneapolis, Minnesota, USA) was implanted after multidisciplinary consultation and a successful trial period. After 8 months, relocation of the pump due to regional pressure problems with surrounding erythema had to occur. A second pump relocation due to pressure problems and skin erosion was needed 18 months after the first relocation, moving from the abdominal wall to the sheath of the rectus abdominis muscle, resulting in resolution of the problems.
CONCLUSIONS: In patients with PPS, intrathecal analgesic drug delivery can be an option to treat chronic, refractory pain. Multidisciplinary consultation is necessary to deal with the wide variety of problems in these patients. Skin problems at the site of the pump reservoir can be challenging and time-consuming and, ultimately, can necessitate relocation (or removal) of the device.
Keywords: Infusions, Spinal, Poliomyelitis, Postpoliomyelitis Syndrome, Infusion Pumps, Implantable, Drug Delivery Systems
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946435
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947160
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947567
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948238
Most Viewed Current Articles
21 Jun 2024 : Case report
100,489
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
53,790
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
36,376
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
25,034
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200